The FDA announced on 2024-08-12 that FDC Limited is recalling Timolol Maleate Ophthalmic Solution USP, 0.5% due to a defective container hazard where the cap spike lodges in the nozzle, preventing patients from dispensing the medication.
How to tell if you have it
- Brand: FDC Limited
- Product: Timolol Maleate Ophthalmic Solution USP, 0.5%
- NDC 64980-514-05 (5mL bottle), Lot # 083K063, Exp 10/31/2025
- NDC 64980-514-01 (10mL bottle), Lot # 083I091, Exp 08/31/2025
- Distributed by Rising Pharmaceuticals Inc, Nationwide U.S.A.
The hazard
The hazard involves a defective container where the spike of the cap becomes lodged in the nozzle of the product bottle. This defect prevents patients from getting the solution out of the bottle.
Context
GovInfoNow's records show FDC Limited has 10 other recalls on record since 2024-04-25. Other recent recalls of similar products include FDC Limited Timolol Ophthalmic Solution 0.5% Recall (2025-07-05), FDC Limited Timolol Ophthalmic Solution 10mL Recall (2025-04-18), and FDC Limited recalls Ciprofloxacin Ophthalmic Solution (2025-03-11). Other recent recalls of similar products include Micro Labs Dorzolamide/Timolol Eye Drops Recall (2026-07-22), Apotex Desmopressin Nasal Spray Recall (2026-04-08), and Apotex Brimonidine/Timolol Eye Drops Recall (2026-03-05).